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A Population-based Case–Control Study of Urinary Arsenic Species and 
Squamous Cell Carcinoma in New Hampshire, USA
Diane Gilbert-Diamond,1,2 Zhigang Li,1,2 Ann E. Perry,3 Steven K. Spencer,4 A. Jay Gandolfi,5 and 
Margaret R. Karagas1,2
1Section of Biostatistics and Epidemiology, Department of Community and Family Medicine, 2Norris Cotton Cancer Center, 3Department 
of Pathology, and 4Department of Surgery, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, USA; 5Department of 
Pharmacology and Toxicology, University of Arizona, Tucson, Arizona, USA
Background: Chronic high arsenic exposure is associated with squamous cell carcinoma (SCC) 
of the skin, and inorganic arsenic (iAs) metabolites may play an important role in this association. 
However, little is known about the carcinogenicity of arsenic at levels commonly observed in the 
United States.
oBjective: We estimated associations between total urinary arsenic and arsenic species and SCC in 
a U.S. population.
Methods: We conducted a population-based case–control SCC study (470 cases, 447 controls) in 
a U.S. region with moderate arsenic exposure through private well water and diet. We measured 
urinary iAs, monomethylarsonic acid (MMA), and dimethylarsinic acid (DMA), and summed these 
arsenic species (ΣAs). Because seafood contains arseno lipids and arseno sugars that metabolize into 
DMA through alternate pathways, partici pants who reported seafood consumption within 2 days 
before urine collection were excluded from the analyses. 
results: In adjusted logistic regression analyses (323 cases, 319 controls), the SCC odds ratio (OR) 
was 1.37 for each ln-transformed microgram per liter increase in ln-transformed ΣAs concentration 
[ln(ΣAs)] (95% CI: 1.04, 1.80). Urinary ln(MMA) and ln(DMA) also were positively associated 
with SCC (OR = 1.34; 95% CI: 1.04, 1.71 and OR = 1.34; 95% CI: 1.03, 1.74, respectively). A 
similar trend was observed for ln(iAs) (OR = 1.20; 95% CI: 0.97, 1.49). Percent iAs, MMA, and 
DMA were not associated with SCC. 
conclusions: These results suggest that arsenic exposure at levels common in the United States 
relates to SCC and that arsenic metabolism ability does not modify the association.
citation: Gilbert-Diamond D, Li Z, Perry AE, Spencer SK, Gandolfi AJ, Karagas MR. 
2013. A population-based case–control study of urinary arsenic species and squamous cell 
carcinoma in New Hampshire, USA. Environ Health Perspect 121:1154–1160; http://dx.doi.
org/10.1289/ehp.1206178
Introduction
Nonmelanoma skin cancer is the most com-
mon type of malignancy among whites and has 
considerable related morbidity and health costs 
(Mudigonda et al. 2010). The incidence rates 
of both forms of non melanoma skin cancer—
cutaneous squamous cell carcinoma (SCC) and 
basal cell carcinoma (BCC)—are dramatically 
increasing in the United States (Karagas et al. 
1999; Rogers et al. 2010). Although BCC is 
more common, SCC has a greater tendency to 
metastasize and is responsible for greater mor-
tality (Weinstock et al. 1991). Sunlight expo-
sure, male sex, and older age are well known 
risk factors for SCC (Preston and Stern 1992).
Chronic exposure to arsenic (As) has been 
associated with SCC in regions of Taiwan 
where high exposures through drinking 
water were common (Tseng et al. 1968; Yeh 
et al. 1968); however, it is not clear whether 
lower levels of exposure that are common 
in the United States also are a risk factor 
for SCC. We previously reported increased 
odds of SCC in association with toenail As 
concentrations > 97th percentile [odds ratio 
(OR) = 2.07; 95% confidence interval (CI): 
0.92, 4.66 compared with toenail As less than 
the median] in a case–control study in the 
U.S. state of New Hampshire (Karagas et al. 
2001). Furthermore, we found evidence of a 
positive association with toenail As concen-
trations > 0.105 μg/g (Karagas et al. 2002), 
but not with concentrations below that value. 
Although toenail As concentration is con-
sidered a reliable long-term biomarker of As 
exposure (Garland et al. 1993), toenails pri-
marily accumulate inorganic As (iAs), so our 
previous analysis could not examine specific 
As species that result from As metabolism.
Upon ingestion, iAs is methylated into 
mono methyl arsonic acid (MMAV), which 
is then reduced to mono methyl arsonous 
acid (MMAIII). In a second step, MMAIII is 
methylated to dimethylarsinic acic (DMAV), 
which is then reduced to dimethyl arsinous 
acid (DMAIII) (Vahter 2002). This process 
is incomplete, such that iAs, MMAV, and 
DMAV are all present in the urine, the pri-
mary route of As excretion (Francesconi et al. 
2002). Although MMAIII and DMAIII have 
been detected in the urine of people highly 
exposed to As (Mandal et al. 2001; Valenzuela 
et al. 2005), they have not been found in 
most studies of people exposed to lower levels 
of As (Lindberg et al. 2006; Rivera-Núñez 
et al. 2011). 
Arsenic methylation was initially consid-
ered a detoxification process because MMAV 
and DMAV are considered less toxic than iAs 
and are easily excreted (Gebel 2002; Moore 
et al. 1997). However, growing evidence sug-
gests that MMAIII and DMAIII are more toxic 
than their penta valent forms and that they 
may even be more toxic than iAs (Mass et al. 
2001; Petrick et al. 2000; Styblo et al. 2000). 
Given their differing toxicities, it is likely that 
various As species have different health effects. 
Studies of populations exposed to high levels 
of As suggest that the profile of urinary As 
species may affect As-related skin patholo-
gies; for example, individuals who have lower 
concentrations of urinary MMA relative to 
DMA may be at lower risk of As-induced skin 
lesions (Kile et al. 2011; Yu et al. 2000), non-
melanoma skin cancers combined (Chen et al. 
2003), and BCC (Leonardi et al. 2012). To 
our knowledge, no studies have specifically 
examined the association between As metabo-
lites and skin cancer in a U.S. population, 
nor have any studies focused specifically on 
SCC. We therefore extended our population-
based case–control study in New Hampshire 
to investigate the relation between individual 
urinary As species and the incidence of SCC.
Methods
In collaboration with > 90% of the derma-
tologists and pathologists practicing in New 
Hampshire and bordering areas, we identified 
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incident cases of invasive SCC of the skin that 
were newly diagnosed in residents 25–74 years 
of age from July 2003 through June 2009. 
Study staff reviewed pathology log books and 
medical charts at participating dermatology 
and pathology clinics in order to identify all 
eligible SCC cases. We selected a control group 
of New Hampshire residents from the Center 
for Medicare and Medicaid services (for those 
≥ 65 years of age) and driver’s license records 
provided by the New Hampshire Department 
of Transportation (for those < 65 years of age), 
frequency matched to cases on sex and age 
(25–35, 36–45, 46–50, 51–59, 60–64, 65–69, 
and 70–74 years) (Applebaum et al. 2007). To 
be eligible, cases and controls were required to 
be English-speaking, mentally competent resi-
dents of New Hampshire with a working tele-
phone number. Cases and controls were still 
eligible to participate if they had a previous 
SCC that was diagnosed prior to the study 
period. The enrollment and interviews for 
cases and controls happened concurrently and 
at about the same rate over the course of the 
study. The present analysis includes cases and 
controls interviewed 1 July 2006–10 August 
2011. Of 579 SCC cases confirmed eligible, 
we enlisted 510 (88%), and of the 594 con-
trols, 483 participated (81%).
After study participants gave written 
informed consent, a study staff member 
who was blinded to their case/control status 
interviewed them in person to obtain socio-
demographic, lifestyle, medical, and sun expo-
sure information. Home tap water samples 
were collected from participants’ homes into 
a commercially washed (mineral-free) high-
density polyethylene bottle that meets U.S. 
Environmental Protection Agency standards 
for water collection (I-Chem; Thermo Fisher 
Scientific, Waltham, MA) by study staff wear-
ing individually packed, clean, powder less 
gloves and following a strict protocol to limit 
contamination (Karagas et al. 2001). A urine-
collection kit with instructions and materials 
necessary to collect a first-morning-void urine 
sample was mailed to the participants. The kit 
included a pre labeled screw-top, 120 mL col-
lection container containing 30 μL diammo-
nium diethyl dithio carbamate to stabilize As 
species, an insulated thermos, and instructions 
to refrigerate the urine sample in the thermos 
until giving it to the interviewer later that day. 
In addition, participants were asked to com-
plete a 3-day water, rice, and seafood intake 
record for the 3 days immediately before 
urine collection. All procedures and study 
materials were approved by the Committee 
for the Protection of Human Subjects at 
Dartmouth College.
Water As analysis. Tap water samples 
were tested at the Trace Element Analysis 
Core at Dartmouth using inductively coupled 
plasma mass spectrometry (ICP-MS) with 
a quadrupole collision cell 7500c Octopole 
Reaction System ICP mass spectrometer 
(Agilent) and helium as a collision gas to 
remove poly atomic interferences, as described 
previously by Karagas et al. (2001). The limit 
of detection (LOD) of these analyses ranged 
from 0.002 μg/L to 0.075 μg/L, with detect-
able levels in > 96.7% of the samples. When 
water As measurements were not available, we 
set the water As concentration to one-half the 
LOD. The average coefficient of variation for 
these analyses was 3.22%.
Urinary analysis. Urine samples from 
cases and controls were frozen at –80°C within 
24 hr of collection and shipped on dry ice to 
the University of Arizona, where they were 
analyzed using a high-performance liquid chro-
matography (HPLC) ICP-MS system and pre-
viously described methods (Gilbert-Diamond 
et al. 2011). This As speciation method quanti-
fies the concentration of iAs species (iAsIII and 
iAsV) and organic As species (MMAV, DMAV, 
and arsenobetaine (AsB). No cases or controls 
had concentrations below the DMA LOD 
(0.11 μg/L); 3.6% of cases and 4.5% of con-
trols were below the MMA LOD (0.14 μg/L); 
32.3% of cases and 31.8% of controls were 
below the iAsIII LOD (0.15 μg/L); and 82.1% 
of cases and 87.5% of controls were below the 
iAsV LOD (0.10 μg/L). Urinary As concentra-
tions < LOD were set to one-half LOD. 
We calculated the sum of urinary iAs and 
methylated As species (ΣAs) by summing 
concentra tions of iAs, MMA, and DMA. AsB 
was excluded from this analysis because it 
is thought to pass through the body with-
out being metabolized and is non toxic 
(Francesconi et al. 2002). The percentage of 
each As species (%iAs, %MMA, %DMA) 
in urine samples was calculated by dividing 
the concentration of each species by the con-
centration of ΣAs. We calculated the ratio of 
urinary MMA to iAs as a biomarker of the 
primary methylation capability, and the ratio 
of urinary DMA to MMA as a biomarker of 
the secondary methylation capability (Chen 
et al. 2003). Urinary creatinine was measured 
with a colorimetric assay (Assay #500701; 
Cayman Chemical, Ann Arbor, MI).
Data analysis. We first evaluated the 
associa tion between individual urinary As spe-
cies and factors that could potentially influ-
ence urinary As concentrations in bivariate 
regression models among controls (n = 447). 
Urinary As concentrations were natural log 
(ln)-transformed to improve normality. Self-
reported rice consumption, including cooked 
rice and rice cereals, was converted into 
equivalents of cooked rice using previously 
described methods (Gilbert-Diamond et al. 
2011). To focus on iAs and its methyla tion 
products, we excluded the 275 participants 
who reported eating seafood in the 2 days 
before sample collection. We chose a 2-day 
window based on As excretion dynamics 
(Buchet et al. 1981), although results were 
consistent in a sensitivity analysis that used 
a 3-day window to define non seafood con-
sumers (data not shown). We then fit indi-
vidual generalized linear models with a logit 
transform to estimate ORs for SCC in asso-
ciation with a unit increase in urinary ΣAs, 
iAs, MMA, DMA, %iAs, %MMA, %DMA, 
iAs/MMA, and DMA/MMA. To improve 
normality of urinary As species and reduce the 
influence of potential outliers, we also fit mod-
els with ln-transformed urinary As [ln(As)]. 
We also estimated ORs for SCC according 
to tertiles of urinary As concentrations (based 
on the distribution in the controls) to explore 
possible non linear associations. All models 
were fit with and without adjustment for sex, 
age (continuous), body mass index (BMI; con-
tinuous), education (high school, college, or 
graduate school), smoking status (at time of 
diagnosis/reference age: never, former, cur-
rent), skin reaction to chronic sun exposure 
(very tan, moderately tan, mildly tan, or 
freckle/no tan), and urinary creatinine concen-
tration—a measure of urinary dilution (con-
tinuous). Resources were available to measure 
urinary creatinine only in a subset of samples 
(n = 596), so we used multiple imputation 
and fully conditional specification methods 
to account for missing data (van Buuren 
2007). Models for As percentages and ratios 
were also adjusted for water As concentration 
to control for potential confounding by iAs 
exposure. We performed a sensitivity analysis 
in which we restricted analyses to non–rice 
eaters because rice is known to contain DMA 
(Williams et al. 2005). To account for DMA 
introduced by unreported fish consumption, 
we also did a sensitivity analysis in which we 
further adjusted for urinary AsB. To explore 
whether the association between urinary As 
and SCC varied by duration of current water 
supply use, we stratified participants accord-
ing to the median duration of current water 
supply use (< 17 years or ≥ 17 years) and esti-
mated ORs for SCC using covariate-adjusted 
logistic regression models with ln-transformed 
urinary As as the exposure. All regression 
analy ses were performed with SAS, version 9.2 
(SAS Institute Inc., Cary, NC).
We used a structural equation model to 
simultaneously model associations between 
SCC and urinary As metabolites (iAs, MMA, 
and DMA), water As concentration, and 
rice consumption. The three urinary As vari-
ables are highly correlated and thus ill-suited 
to be included in a single logistic regression 
model. The structural equation model permits 
iAs, MMA, and DMA to each load differ-
ently onto a single latent urinary As variable 
(UAM) based on their correlation structure; 
the loading score of each As species indicates 
its relative contribution to the variable. Robust 
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weighted least-square estimators were used to 
estimate parameters in the model. We used 
the comparative fit index (Bentler 1990) and 
Tucker–Lewis index (Tucker and Lewis 1973) 
to evaluate the model fit. We calculated the 
indirect association between water As and SCC 
and rice consumption and SCC, through the 
latent UAM variable, and tested its statisti-
cal significance using the Sobel Z test (Shrout 
and Bolger 2002). For the purpose of com-
parison, we also created a UAM model with-
out the assumption of unobserved variables 
by replacing the latent UAM variable with the 
simple sum of the three urinary As metabolites 
in the model. The type I error rate used to 
define statistical significance is 0.05 for these 
models. The structural equation model analy-
sis was conducted using Mplus, version 6.12 
(Muthén & Muthén, Los Angeles, CA).
Results
The mean (± SD) time between SCC diag-
nosis and interview/urine collection was 
23 ± 10.2 months. Urine samples were col-
lected from 470 SCC cases (92%) and 
447 controls (75%), resulting in a total sample 
size of 917. The sex and age distributions and 
the percentage of urban versus rural residence 
did not differ for eligible cases and those who 
participated in our study. The sex distribu-
tion and percentage of urban versus rural 
resi dence also did not differ between iden-
tified controls and those who participated 
in our study; however, controls who did 
partici pate tended to be older (63 years vs. 
56 years). In cases inter viewed for our study, 
98.5% of those 25–64 years of age had a 
valid driver’s license at the time of interview, 
and 98% of those 65–74 years of age were 
enrolled in Medicare, thus indicating that 
most would have been included in the data 
sources used to identify controls. The sex 
and age group distributions for SCC cases 
and controls were similar, and approximately 
99% of all partici pants reported their race as 
white (Table 1). In addition, urban versus 
rural residence as well as the type of house-
hold water supply and length of use were 
similar between cases and controls, with 58% 
of cases and 54% of controls consuming 
water from a shared or private well and an 
overall median water supply usage of 17 and 
18 years, respectively. The consumption of 
fish and rice in the 2 days immediately before 
urine collection was also similar in cases and 
controls. Compared with controls, cases 
generally had an increased sun sensitivity, 
measured as a lower tendency to tan with 
chronic sun exposure (Table 1). On average, 
cases also had a lower BMI, higher level of 
education, and lower likelihood to have ever 
smoked compared with controls.
Median urinary ΣAs, iAs, MMA, and 
DMA concentrations were higher in cases 
than controls (Table 1). In bivariate analyses 
restricted to controls, age, BMI, and water As 
concentration were associated with ln-trans-
formed concentrations of urinary ΣAs, iAs, 
MMA, and DMA (see Supplemental Material, 
Table S1). In addition, male sex was associated 
with higher urinary ln(iAs) and ln(MMA), 
and a higher education level was associated 
with higher urinary ln(ΣAs), ln(iAs), and 
ln(DMA). Seafood consumption was associ-
ated with higher urinary ΣAs, largely because 
of higher urinary DMA; each 4-oz. serving 
Table 1. Selected characteristics of squamous cell carcinoma (SCC) cases and controls [n (%) or 
median (IQR)].
Variable SCC cases (n = 470) Controls (n = 447)
Sex
Male 284 (60.4) 258 (57.7)
Female 186 (39.6) 189 (42.3)
Age (years)
< 50 19 (4.0) 34 (7.6)
50–59 91 (19.4) 83 (18.6)
60–69 213 (45.3) 203 (45.4)
≥ 70 147 (31.3) 127 (28.4)
BMI (kg/m2)
< 18.5 6 (1.3) 3 (0.7)
18.5–24.9 155 (33.4) 127 (28.6)
25.0–29.9 178 (38.4) 161 (36.3)
> 30.0 125 (26.9) 153 (34.5)
Missing (n) 6 3
Race
White 465 (99.8) 439 (98.7)
Nonwhite 1 (0.2) 6 (1.3)
Missing (n) 4 2
Skin reaction to chronic sun exposure
Very tan 69 (14.7) 134 (30.0)
Moderately tan 239 (51.1) 235 (52.7)
Mildly tan 121 (25.9) 60 (13.5)
Freckle/no tan 39 (8.3) 17 (3.8)
Missing (n) 2 1
Smokinga
Never-smoker 207 (44.0) 160 (35.8)
Former smoker 207 (44.0) 212 (47.4)
Current smoker 56 (11.9) 75 (16.8)
Highest level of education
High school 116 (24.7) 181 (40.5)
College 192 (40.9) 160 (35.8)
Graduate school 161 (34.3) 106 (23.7)
Missing (n) 1 0
Residence
Urban 64 (13.6) 48 (10.7)
Rural 406 (86.4) 399 (89.3)
Household water supply
Public 188 (40.8) 203 (46.4)
Shared well 27 (5.9) 20 (4.6)
Private well or spring 242 (52.5) 214 (48.9)
Other 4 (0.1) 1 (0.2)
Missing (n) 9 9
Seafood consumption
Yes 147 (32.5) 128 (30.1)
No 305 (67.5) 297 (69.9)
Missing (n) 18 22
Rice consumption
Yes 98 (21.8) 96 (22.6) 
No 351 (78.1) 328 (77.4)
Missing (n) 21 23
Years used water supply 17 (8–32) 18 (8–34)
Water As (μg/L) 0.33 (0.14–1.11) 0.31 (0.12–0.94)
Urinary As (μg/L)
ΣAsb 5.27 (3.38–8.52) 4.76 (2.94–8.10)
iAs 0.34 (0.13–0.59) 0.30 (0.13–0.54)
MMA 0.52 (0.31–0.82) 0.45 (0.29–0.75)
DMA 4.37 (2.72–7.25) 3.73 (2.37–6.70)
AsB 7.36 (1.69–29.01) 5.79 (1.13–26.34)
Abbreviations: AsB, arsenobetaine; DMA, dimethylarsinic acid; iAs, inorganic arsenic; IQR, interquartile range; MMA, 
monomethylarsonic acid.
aAssessed at time of diagnosis/reference age. bSum of iAs, MMA, and DMA.
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of seafood was associated with an estimated 
53% (95% CI: 37%, 71%) increase in urinary 
DMA concentration.
Among participants who reported not eat-
ing seafood in the 2 days prior to urine col-
lection (323 cases, 319 controls), we observed 
a linear association between SCC and ΣAs, 
MMA, and DMA (Table 2). After adjust-
ment for sex, age, BMI, education, smoking 
status, skin reaction to chronic sun exposure, 
and urinary creatinine the OR of SCC was 
1.33 for each 1-μg/L increase in urinary MMA 
(95% CI: 1.04, 1.70) (Table 2). Urinary ΣAs 
and DMA were also associated with increased 
odds of SCC. Positive associations with SCC 
were also observed after ln-transforming the 
urinary As variables. The OR for each ln-trans-
formed microgram per liter increase of ln(ΣAs) 
was 1.37 (95% CI: 1.04, 1.80). The ORs for 
each 1-ln(μg/L) increase in ln(MMA) and 
ln(DMA) were 1.34 (95% CI: 1.04, 1.71) and 
1.34 (95% CI: 1.03, 1.74), respectively. In 
contrast, SCC was not associated with the per-
centage of urinary As species or As methylation 
ratios (see Supplemental Material, Table S2). 
Results were not sensitive to creatinine adjust-
ment (data not shown). In addition, results 
were not substantially different when using a 
3-day window to define seafood consumers, 
nor after further adjustment for urinary AsB 
(data not shown). Regression coefficients were 
similar in unadjusted and adjusted models after 
excluding an additional 65 cases and 59 con-
trols who reported eating rice in the previ-
ous 2 days, although the smaller sample size 
resulted in slightly wider confidence intervals 
(see Supplemental Material, Table S3).
Urinary MMA concentration was signifi-
cantly associated with odds of SCC when 
urinary As was examined by tertiles of expo-
sure (Table 2). Participants in tertile 3 of uri-
nary MMA had 76% higher odds of SCC 
than those in tertile 1 (OR = 1.76, 95% CI: 
1.09, 2.84). Participants in tertile 3 of urinary 
ΣAs, iAs, and DMA also had increased odds 
of SCC, although none of the ORs reached 
statistical significance.
In an analysis stratified by the median 
duration of current water supply usage, ORs 
for SCC were positively associated with unit 
increases in ln-transformed urinary As spe-
cies in both strata (< 17 years and ≥ 17 years) 
(Table 3). ORs were somewhat larger among 
those with a shorter duration of current 
water usage, but the differences in the slopes 
between the two strata were not statistically 
significant.
In a structural equation model adjusted 
for the same set of covariates, iAs, MMA, and 
DMA each contributed significantly to the 
latent UAM variable (loading scores = 0.80, 
0.52, and 0.49, respectively) (see Supplemental 
Material, Figure S1). The comparative fit index 
(> 0.90) and the Tucker Lewis Index (> 0.90) 
indicated a reasonable model fit. We found 
an association between the latent UAM vari-
able and SCC [OR per 1-SD increase = 2.04 
(95% CI: 1.35, 3.10)]. Water As concen-
tration was associated with the latent UAM 
variable [1-SD increase in UAM for each 
10-μg/L increase in water As = 0.32 (95% CI: 
0.30, 0.34)]; the indirect association between 
water As concentration and SCC through 
UAM was also significant [for every 1-μg/L 
increase in water As, OR = 1.02 (95% CI: 
1.01, 1.04)]. The structural equation model 
that did not assume unobserved variables (see 
Supplemental Material, Figure S2) also showed 
a significant, but weaker, association between 
ΣAs and SCC [for each 1-unit increase of ΣAs, 
OR = 1.02 (95% CI: 1.00, 1.03)]. 
Discussion
In this U.S. population–based case–control 
study of participants living in a region with 
detectable As in drinking water, we estimated 
positive associations between SCC and uri-
nary ΣAs, MMA, and DMA concentrations. 
The results of our structural equation model 
analysis suggest that a latent urinary As vari-
able representing urinary iAs, MMA, and 
DMA is associated with SCC. In contrast, 
Table 2. Unadjusted and adjusted ORs (95% CIs) of squamous cell carcinoma (SCC) by urinary As 
concentration units or tertiles among cases and controls who did not report seafood consumption for the 
2 days prior to urine sample collection (323 cases, 319 controls).
Predictor Unadjusteda Adjustedb
Untransformed urinary As (μg/L)
ΣAs 1.03 (1.00, 1.05) 1.03 (1.00, 1.06)
iAs 1.21 (0.96, 1.53) 1.26 (0.98, 1.61)
MMA 1.30 (1.03, 1.64) 1.33 (1.04, 1.70)
DMA 1.03 (1.00, 1.06) 1.03 (1.00, 1.07)
ln-Transformed urinary As (μg/L)
ln(ΣAs) 1.29 (1.04, 1.60) 1.37 (1.04, 1.80)
ln(iAs) 1.19 (0.99, 1.43) 1.20 (0.97, 1.49)
ln(MMA) 1.26 (1.04, 1.53) 1.34 (1.04, 1.71)
ln(DMA) 1.27 (1.03, 1.56) 1.34 (1.03, 1.74)
Urinary As tertiles (μg/L)c
ΣAs 
Tertile 1 (< 3.36) 1 (reference) 1 (reference)
Tertile 2 (3.36 to < 5.31) 0.93 (0.63, 1.38) 0.94 (0.60, 1.45)
Tertile 3 (≥ 5.31) 1.39 (0.96, 2.03) 1.43 (0.91, 2.27)
iAs
Tertile 1 (< 0.23) 1 (reference) 1 (reference)
Tertile 2 (0.23 to < 0.45) 0.92 (0.63, 1.36) 0.97 (0.63, 1.48)
Tertile 3 (≥ 0.45) 1.30 (0.89, 1.90) 1.27 (0.82, 1.98)
MMA
Tertile 1 (< 0.35) 1 (reference) 1 (reference)
Tertile 2 (0.35 to < 0.59) 1.01 (0.68, 1.51) 1.06 (0.68, 1.65)
Tertile 3 (≥ 0.59) 1.61 (1.10, 2.35) 1.76 (1.09, 2.84)
DMA
Tertile 1 (< 2.61) 1 (reference) 1 (reference)
Tertile 2 (2.61 to < 4.18) 0.93 (0.63, 1.38) 0.92 (0.60, 1.43)
Tertile 3 (≥ 4.18) 1.47 (1.01, 2.13) 1.53 (0.97, 2.41)
ΣAs, sum of inorganic arsenic (iAs), monomethylarsonic acid (MMA), and dimethylarsinic acid (DMA). 
aFrom general linear models with the logistic link function and case/control status as the outcome. bModels adjusted for 
sex, age (continuous), BMI (continuous), education (high school, college, graduate school), smoking status at diagnosis/
reference age (never, former, current), skin reaction to chronic sun exposure (very tan, moderately tan, mildly tan, freckle/
no tan), and urinary creatinine concentration (continuous). cTertiles were calculated using the urinary As distribution of 
the study controls. 
Table 3. Adjusted ORs (95% CIs) of squamous cell carcinoma (SCC) by ln‑transformed urinary As concen‑
tration among participants who did not report seafood consumption for the 2 days prior to urine sample 
(323 cases, 319 controls), with data stratified at the sample median of current water supply use duration.
Predictor




(163 cases, 159 controls)
≥ 17 
(160 cases, 160 controls)
ln(ΣAs) (μg/L) 1.55 (1.04, 2.32) 1.20 (0.81, 1.80) 0.38
ln(iAs) (μg/L) 1.29 (0.95, 1.76) 1.09 (0.79, 1.50) 0.51
ln(MMA) (μg/L) 1.59 (1.10, 2.32) 1.14 (0.80, 1.64) 0.21
ln(DMA) (μg/L) 1.46 (0.99, 2.14) 1.22 (0.83, 1.79) 0.45
ΣAs, sum of inorganic arsenic (iAs), monomethylarsonic acid (MMA), and dimethylarsinic acid (DMA). 
aFrom general linear models with the logistic link function, ln‑transformed urinary As as the predictor, and SCC case/
control status as the outcome; models are adjusted for sex, age (continuous), BMI (continuous), education (high school, 
college, graduate school), smoking status (never, former, current), skin reaction to chronic sun exposure (very tan, 
moderately tan, mildly tan, freckle/no tan), and urinary creatinine concentration. bt-Test on the difference of the slopes, 
assuming unequal variances. 
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percentages and ratios of the individual 
metabolites were not associated with SCC in 
the study population.
In our analysis, we were interested in 
ingested iAs and the products of its methyla-
tion: MMA and DMA. In our population, 
where water As concentrations are relatively 
low, dietary sources of iAs can play a more sub-
stantial role in overall As exposure (European 
Food Safety Authority 2009). For example, 
previous studies have found rice consump-
tion to be a significant predictor of urinary iAs 
(Cascio et al. 2011; Gilbert-Diamond et al. 
2011). In our adult study population, however, 
the prevalence of rice consumption was only 
22% in the 2 days immediately before urine 
collection and was not significantly associated 
with urinary iAs (see Supplemental Material, 
Table S1). Seafood is the main dietary source 
of organic As compounds, including AsB, 
arseno lipids, and arseno sugars, and the latter 
two compounds are metabolized into DMA 
(Cullen and Reimer 1989; Francesconi 2010). 
Other studies have reported seafood consump-
tion as a major predictor of urinary DMA in 
U.S. populations (Navas-Acien et al. 2011; 
Rivera-Núñez et al. 2012), as we observed 
in our study population (see Supplemental 
Material, Table S1). Given the different bio-
transforma tion pathways of iAS and organic 
As compounds that result in DMA, as well as 
their potential differing toxicity (Cullen and 
Reimer 1989), we excluded participants who 
reported seafood consumption for the 2 days 
prior to urine collection. Although rice con-
sumption was a significant predictor of uri-
nary DMA in our study (see Supplemental 
Material, Table S1), we chose not to exclude 
rice consumers from our analysis because 
we were interested in all potential sources of 
ingested iAs. However, results of sensitivity 
analyses that excluded rice consumers were 
generally consistent with the main analyses (see 
Supplemental Material, Table S3).
Previous ecological studies in the As 
endemic region of southwest Taiwan (Tseng 
et al. 1968; Yeh et al. 1968) support an asso-
ciation between high levels of As exposure 
through well water and SCC. Consistent with 
our previous work using toenail As as a bio-
marker (Karagas et al. 2001), results from the 
present study of urinary As suggest that the 
association between As and SCC extends to 
lower levels of As exposure. To our knowledge, 
no other studies have examined urinary As spe-
cies and SCC in populations with similar levels 
of As exposure for direct comparison. Studies in 
more highly exposed populations have exam-
ined urinary As species and As-induced skin 
pathologies. For example, the Health Effects 
of Arsenic Longitudinal Study (HEALS) in 
Bangladesh reported that total urinary As was 
associated with the risk of incident skin lesions 
[including melanosis and keratosis, known 
precursors to skin cancer (Sober and Burstein 
1995; Woolgar and Triantafyllou 2011)] in 
a cohort of 10,182 adults (Argos et al. 2011). 
In a cross-sectional study of 76 residents of an 
As endemic region of Mexico with drinking 
water As concentrations ≥ 50 μg/L, urinary 
MMAIII was significantly higher among those 
with As-related skin lesions (n = 55) compared 
with those without (n = 21); however, there 
was no difference in concentrations of MMAV, 
DMAIII, DMAV, iAsIII, iAsV, or the sum of 
iAs and methylated As species (Valenzuela 
et al. 2005). The percentage or ratio of uri-
nary As metabolites is thought to reflect indi-
vidual differences in the ability to metabolize 
iAs, and there is some evidence that they 
reflect increased susceptibility to As-induced 
skin lesions. For example, in a case–control 
study (n = 76 cases, 224 controls) in southwest 
Taiwan, Chen et al. (2003) reported that a 
low urinary DMA:MMA ratio was positively 
associated with skin cancer (BCC or SCC) 
in participants with high lifetime exposure to 
As (> 15 mg/L per year). In another smaller 
Taiwanese case–control study (n = 26 cases, 
26 controls), Yu et al. (2000) reported that 
individuals with > 15.5% MMA had signifi-
cantly higher odds of skin disorders (including 
BCC, SCC, and hyperkeratosis/hyperpigmen-
tation) than did those with ≤ 15.5% MMA 
(OR = 5.5). In 594 cases and 1,041 controls 
in the HEALS study, urinary %MMA and 
the DMA:MMA ratio were significantly asso-
ciated with skin lesions (including keratosis 
and melanosis) (Ahsan et al. 2007); the top 
quartile of %MMA (median, 20.2%) was 
associated with increased odds of skin lesions 
compared with the lowest quartile (median, 
7.5%) [OR = 1.57 (95% CI: 1.10, 2.26)], 
and the top quartile of DMA:MMA (median, 
10.9) was associated with reduced odds of 
skin lesions compared with the lowest quar-
tile (median, 3.1) [OR = 0.64 (95% CI: 
0.44, 0.91)]. In another large Bangladeshi 
case–control study of skin lesions (includ-
ing SCC as well as keratosis and melanosis; 
n = 859 cases, 868 controls), Kile et al. (2011) 
reported an OR of 1.56 (95% CI: 1.15, 2.12) 
associated with each increase in log10 percent-
age of MMA. At the relatively low levels of 
As exposure in our population in the present 
study, SCC was associated with the absolute 
concentrations of MMA and DMA measured 
in urine but not the relative proportions of 
MMA, DMA, and iAs. Thus, it is not clear 
whether differences in the proportion of As 
metabolites reflect susceptibility to skin can-
cers at lower levels of exposure. 
The observed association between 
methylated forms of As and SCC may reflect 
the carcino genicity of those methylated forms 
or their chemical predecessors. iAs is known 
to be carcinogenic, although the biological 
mechanisms are not yet fully understood 
(International Agency for Research on Cancer 
2004). In experimental systems, iAs exposure 
leads to increased generation of reactive oxygen 
species (ROS), which in turn lead to DNA 
damage and increased oxidative sensitive gene 
expression (Shi et al. 2004). For example, in 
a recent in vitro study in human immortalized 
lung epithelial cells and adeno carcinoma cells, 
Liu et al. (2011) reported that As-induced 
ROS generation activated protein kinase AKT 
and the extra cellular signal-regulated kinase 
(ERK1/2) leading to increased downstream 
expression of vascular endothelial growth 
factor (VEGF), an important angio genesis 
regulator. iAs may be carcino genic through 
promotion of mito chondrial activity, a process 
that could fuel the increased energy demands 
of quickly replicating cells, as well as lead to 
increased ROS generation (Lee et al. 2011). 
Arsenic exposure may also promote carcino-
genesis through altering the methyla tion of 
oncogenes and tumor suppressor genes 
(reviewed by Cheng et al. 2012). This altered 
DNA methylation may result from a depletion 
of cellular S-adenosyl methionine (Coppin 
et al. 2008; Reichard and Schnekenburger 
2007; Zhao et al. 1997), an essential methyl 
donor, by the As methylation pathway. It is 
still unclear whether iAs methylation products 
are equally—or even more—carcinogenic 
compared with iAs. In an in vitro study of 
human epidermal keratino cytes, Vega et al. 
(2001) showed that tri valent and penta-
valent MMA and DMA affected cellu-
lar viability, proliferation, and cyto kine 
excretion to approximately the same extent as 
their inorganic counter parts. Another study 
of human keratino cytes showed evidence 
that MMAIII may be even more cytotoxic 
than iAsIII (Styblo et al. 2000). There is also 
in vitro evidence of greater geno toxicity of 
MMAIII (Mass et al. 2001; Schwerdtle et al. 
2003) and DMAIII (Schwerdtle et al. 2003) 
compared with iAsIII and that the genotoxicity 
is mediated by ROS (Nesnow et al. 2002). 
Further work is necessary to clarify the biologi-
cal mechanisms of As carcinogenicity and to 
understand the relative carcinogenicity of iAs 
and its metabolites in the in vivo context.
In the present study we were unable to 
measure urinary As prior to SCC diagnosis. 
Therefore, we cannot exclude the possibility 
that cases could have changed some behaviors 
related to As exposure after their diagnosis 
and before urine collection. In addition, it 
is possible that SCC treatment could have 
resulted in changes in As excretion; however, 
this is unlikely because the primary treatment 
for SCC is surgical removal of the carcinoma. 
Prospective studies are needed to better under-
stand the temporality of the observed associa-
tion. Prospective studies can also elucidate the 
latency period of low-dose As exposure and 
associated SCC, which is currently unknown. 
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Another limitation of our study is that 
we have a single urinary As measurement, 
which may not adequately reflect long-term 
exposure. In a U.S. study of Native American 
populations (n = 60), Navas-Acien (2009) 
found that urinary As excretion (including 
As concentrations and percent of urinary 
As species) remained fairly constant over a 
10-year period. In a study in Bangladesh that 
measured urinary As in 196 participants over 
2 years, Kile et al. (2009) also found that the 
concentrations of urinary As species were 
fairly reproducible over time, but the per-
cent of As species varied. Studies from Chile 
(n = 73) (Hopenhayn-Rich et al. 1996) and 
the United States (n = 81) (Steinmaus et al. 
2005) reported that proportions of As species 
were fairly stable over time, but only over 
2 months and 1 year, respectively. Overall, 
findings from previous studies suggest that a 
single urinary measurement may be a reliable 
measure of exposure for a period of months to 
years. We recognize, however, that the latency 
period for As exposure could be very long. 
Our participants tended to use the same water 
source for many years (median, 17 years); 
although water As concentration was asso-
ciated with urinary As (see Supplemental 
Material, Table S1), other factors such as 
diet also influence As exposure (European 
Food Safety Authority 2009). ORs stratified 
by the duration of current water system use 
did not significantly differ (Table 3). Our 
study was also limited by the fact that we 
were unable to measure As concentrations 
directly in the tissue of interest, the skin. 
Further understanding about As metabolism, 
tissue distribution, and excretion is necessary 
to understand the biological interpretation of 
the associations between urinary As and SCC 
in our study population.
Conclusion
Using sensitive methods to measure urinary As 
exposure in a population-based study of SCC 
in residents of New Hampshire, we observed 
that urinary concentrations of ΣAs, MMA, 
and DMA were positively associated with 
SCC. These findings suggest that common 
exposure levels may influence cancer risk in 
the United States and elsewhere.
correction
In Table 1 of the manuscript originally 
published online, the numbers of SCC 
cases under “highest level of education” 
were incorrect. In addition, for seafood and 
rice consumption, the values for cases and 
controls were switched, and the numbers 
for “missing” were accidentally included 
in the “no” totals. The errors have been 
 corrected here.
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